emaktab.uz vs vercel.app
Market traction comparison · Updated Jul 2026
| emaktab.uz | vercel.app | Leads | |
|---|---|---|---|
| Monthly Visits | 596.5K | 181.4M | vercel.app |
| Bounce Rate | 38.1% | 45.6% | emaktab.uz |
| SEO & Keywords | 30 | 35 | vercel.app |
| Domain Age | 3y 4m | 6y 7m | vercel.app |
vercel.app leads in 3 of 4 dimensions, while emaktab.uz leads in 1.
Growth Momentum
| emaktab.uz | vercel.app | Leads | |
|---|---|---|---|
| Monthly Visits | 596.5K | 181.4M | vercel.app |
| MoM Change | -59% | +10% | vercel.app |
| Avg. Session | 3m07s | 5m12s | vercel.app |
| Pages / Visit | 8.0 | 4.8 | emaktab.uz |
Growth Momentum · Insight
emaktab.uz is losing traffic (-59%) despite 596.5K monthly visits. vercel.app's +10% growth puts it on a trajectory to overtake.
Acquisition Strategy
| emaktab.uz | vercel.app | Leads | |
|---|---|---|---|
| Primary Channel | Direct 47% | Direct 75% | |
| Bounce Rate | 38.1% | 45.6% | emaktab.uz |
| SEO & Keywords | 30 | 35 | vercel.app |
Keyword Overlap Rate: 35%
Acquisition Strategy · Insight
emaktab.uz acquires users primarily through Direct (47%), while vercel.app relies on Direct (75%). This reflects fundamentally different go-to-market strategies — vercel.app's higher direct traffic suggests stronger brand recognition or product-led growth, while emaktab.uz's search reliance means growth is more scalable but more vulnerable to algorithm changes.
Business Maturity
| emaktab.uz | vercel.app | Leads | |
|---|---|---|---|
| Domain Age | 3y 4m | 6y 7m | vercel.app |
| Registered | Apr 2023 | Jan 2020 | |
| Expires | Apr 2027 | Jan 2036 |
Business Maturity · Insight
vercel.app has been in the market 3 years longer (7y vs 3y). vercel.app's longer track record suggests established operations, while emaktab.uz's entry timing indicates the market still attracts new players.
Market Position
| emaktab.uz | vercel.app | Leads | |
|---|---|---|---|
| Global Rank | #56.9K | #208 | vercel.app |
| Category Rank | — | #7 | |
| PH Upvotes | — | 381 |
emaktab.uz only
vercel.app only
Market Position · Insight
emaktab.uz is heavily concentrated in Uzbekistan (95%), creating dependency risk on a single market. vercel.app has a more diversified audience.
Each has untapped markets the other serves: emaktab.uz could expand into India, Brazil, Japan, while vercel.app could target Uzbekistan, Russia, Azerbaijan.
Key Takeaways
- •emaktab.uz is losing traffic (-59%) despite 596.5K monthly visits. vercel.app's +10% growth puts it on a trajectory to overtake.
- •emaktab.uz acquires users primarily through Direct (47%), while vercel.app relies on Direct (75%). This reflects fundamentally different go-to-market strategies — vercel.app's higher direct traffic suggests stronger brand recognition or product-led growth, while emaktab.uz's search reliance means growth is more scalable but more vulnerable to algorithm changes.
- •vercel.app receives 304.1x more monthly traffic than emaktab.uz (181.4M vs 596.5K).
- •vercel.app is growing (+10%) while emaktab.uz is declining (-59%).
- •vercel.app keeps visitors significantly longer (5m12s avg session vs emaktab.uz's 3m07s), suggesting deeper product engagement or stickier content.
- •They share 17 keywords (35% overlap), indicating direct search competition.
You've seen the gap. Now steal the playbook.
A Growth Teardown reverse-engineers exactly how each product grows — traffic sources, backlink strategy, keyword gaps, and scored action items you can copy this week.
Related Comparisons
Report based on data from July 2026